Summary. The plasma concentration of a pituitary hormone is determined by the rate of secretion, degradation, and the volume of distribution of that hormone. Using a radioimmunoassay for human thyrotropin (TSH) and human TSH-1811, we have estimated the rates of degradation and distribution of TSH in man and calculated the rate of secretion. Either 0.5 or 5 jug of TSH-131I with specific activities of 1 to 50 pc per ptg was administered intravenously to 12 euthyroid subjects. Serial determinations were made of TSH-131I, and the half-time of disappearance (tj) was thus estimated. The average tj in euthyroid subjects was 53.9 minutes with a volume of distribution averaging 5.8% of body weight. The mean endogenous plasma TSH concentration was 1.8 mpg per ml (2.7 JLU per ml in terms of the human TSH reference standard A). The mean total TSH pool, excluding the pituitary, was 5.8 ug (8.7 mU). From these data the mean secretion rate of TSH in euthyroid man was calculated to be 110.1 tg per day (165.2 mU).
Introduction
Relatively little information is available on the rate of turnover and secretion of thyrotropin in man or laboratory animals. Using bioassays, several workers have estimated the disappearance rate of relatively large amounts of heterologous TSH (bovine) administered to the rat (1) (2) (3) (4) . In these studies the half-time of disappearance was between 2 and 5 minutes. Similar studies in the rabbit (5) revealed a t1 of about 35 minutes; the tj of TSH in hypothyroid rabbits was longer than that in euthyroid animals. Hendrich and Turner (6) have estimated the secretion rate of TSH in chickens by first labeling the thyroid glands with 131I and determining the rate of release of this thyroidal 131J, then suppressing endogenous TSH with thyroxine. The amount of injected bovine TSH required to return the rate of release of thyroidal 131I to normal was said to be equivalent to the amount of endogenous TSH secreted. By this 953 technique the secretion rate was estimated to average about 2.5 USP 1 mU per 100 g body weight per day. In 1962 Bakke, Lawrence, and Roy (7) reported estimates of t1 and secretion rates of TSH in man. In these studies 7 .5 to 40 U of bovine TSH was administered intravenously and the t4 estimated by following disappearance by bioassay. The mean t1 in eumetabolic adults was 35 .5 minutes, whereas the tj in hypothyroid patients averaged 97.9 minutes. The secretion rate in euthyroid adults was estimated to be about 260 USP mU per day. The rate was about 10 times greater in hypothyroid patients. Although these studies were elegantly done, the conclusions might be challenged because of two limitations in the methodology available. First, the amounts of TSH utilized were not tracer amounts. According to our data, more than 10 times the total body pool of TSH was administered. It has been shown previously that the t4 values for certain hormones (e.g., cortisol) are different when measured after administration of tracer and large doses of hormone (8) . Second, bovine TSH was administered to man. In earlier studies (9) we have demonstrated almost complete lack of immunological cross-reaction of bovine and human TSH, suggesting that there are structural differences between human and bovine TSH. One might then question whether the human organism disposes of bovine TSH in an identical fashion to the human hormone.
For these reasons we have estimated the ti, distribution volume, and the secretion rates of TSH in man using tracer amounts of highly purified human TSH labeled with 131I. Endogenous plasma TSH levels were determined by radioimmunoassay (10, 11) .
Methods
Highly purified human TSH was utilized in these studies. This material has been studied by several techniques to ascertain its degree of purification; these studies have been previously reported (9, 11) . At the time of preparation, it contained 20 USP U per mg. When antisera prepared against this preparation were allowed to react against it in agar gel, a single line of precipitation was observed (9) . In these studies, no lines of reaction were observed against bovine TSH even when 200 times more than the human TSH was utilized. In addition, when this TSH was radioiodinated as described later and the iodinated material permitted to react against these antisera, radioautography revealed a similar single precipitation line. The contaminant present in largest amounts was human luteinizing hormone, which accounted for 2 to 5% of the TSH preparation by weight. It is known, however, that this TSH preparation is contaminated with small amounts of other polypeptides, for highly potent antisera prepared against it result in 2 to 3 precipitation lines when reacted against crude human pituitary powder. This TSH was labeled with '31I (TSH-"I) to yield SA of 1 to 50 /Ac per ,Ag by the method of Greenwood, Hunter, and Glover (12) . Lower specific activities than those described in our previous publication (9) were utilized to minimize "damage" to the hormone. Each TSH-'13I preparation was sterilized by Millipore filtration, tested for sterility and pyrogenicity, and used as soon as such studies proved negative (within 2 to 3 days). Eighty-five to 95% of the TSH-"'I was precipitable by excess anti-TSH, and 95 to 100%o was precipitable with 10% trichloroacetic acid (TCA). Adult euthyroid or hypothyroid patients were treated with 4 to 6 drops of a saturated solution of potassium iodide each 6 hours for 24 hours before study.
This prevented significant thyroidal trapping of the "~'I released during degradation of the TSH-'11. Either 0.5 or 5.0 ltg of TSH-131I diluted in 0.5 to 1.0 ml of 0.9% NaCl was injected intravenously into each patient, and serial 10-ml heparinized venous blood samples were obtained via an indwelling needle at various time intervals. Patients were given liberal water intake during the period of study, and urine was collected periodically for 24 hours.
The total "31I content of 1 ml of the plasma samples was determined in a well-type scintillation counter.
TSH-mI content was determined either by reacting the TSH-1311 with an excess of the same antihuman TSH serum utilized for radioimmunoassay of TSH and separating antibody bound from free TSH-"'I by the double antibody technique of Feinberg (13), as modified by Morgan, Sorenson, and Lazarow (14), or by precipitating the TSH-mI with an equal volume of 10%o TCA.
All of the samples collected between 20 and 120 minutes from 4 patients were studied by both procedures, and during this time interval no significant differences in the results using the two techniques were found. Endogenous TSH was determined by radioimmunoassay of plasma as previously reported (11) .
To determine TSH in plasma from euthyroid patients, we utilized the procedure described by Bates (15) for extraction and prepared 5-to 10-fold concentrates. TSH losses during extraction were quantitated by measuring the recovery of either tracer TSH-131I or bovine TSH added to plasma samples. When the latter technique was used, bovine TSH was measured by specific radioimmunoassay (9) . Recovery ranged from 50 to 80%, and the average figure of 65%o was utilized to correct for loss of TSH during extraction.
The slope of the disappearance curve of TSH-mI was calculated by the method of least squares, and tj was cal- The volume of distribution for the 3 patients was similar to that for the euthyroid subjects. The endogenous concentration of TSH averaged 13.2 m/Ag (19.8pMU) per ml. The total body pool of TSH, excluding the pituitary, was some 5 to 25 times the TSH pool in the euthyroid subjects. The secretion rates of TSH for these 3 hypothyroid patients averaged 688.7 Mkg (983.1 mU) per 24 hours.
As further support for the similarity between the disappearance of TSH-131I and of endogenous TSH, the disappearance of endogenous TSH was studied in 3 other young patients after intravenous injections of 500 Mg of i-thyroxine or triiodothyronine. One of the patients, initially euthyroid, had plasma TSH elevated to 14 mug per ml by 12 days' treatment with oral methimazole and presumably had low iodine stores before treatment.
The tj of TSH in this patient could not be accurately determined but was more than 30 and less than 60 minutes. Two myxedematous patients had tj of 90 and 130 minutes, respectively. Data from one of these patients are shown in Figure 4 .
Discussion
The assumption that a steady state of TSH secretion existed during the course of these studies is supported by earlier studies. Although the present sensitivity of the radioimmunoassay for TSH does not permit detection of TSH in all euthyroid subjects, measurements throughout the day in subjects with slight elevations in plasma 3 Milliunits human TSH standard A. TSH have failed to reveal diurnal variations. Plasma TSH levels were in fact found to be remarkably constant from day to day and during different portions of the day in any one individual (11) .
The average tj of TSH in the euthyroid subjects estimated from these studies was 53.9 minutes. Several studies were performed to ascertain that the TSH-131I was actually degraded during this time interval, and not merely distributed in a larger space. 1) Nonantibody precipitable and non-TCA soluble 131I appeared in the urine, and 100%o of the radioactivity could be recovered in 12 to 24 hours. 2) The disappearance was linear during disappearance of 90%o or more of the hormone, and 3) endogenous TSH and TSH-131I disappeared with a similar tj. In earlier studies (9) we demonstrated that this TSH-l31I retained biological activity.
The slower disappearance of TSH in hypothyroidism could be due either to overloading of normally functioning degradative mechanisms or to slower catabolism by a high capacity system. The latter interpretation seems most likely in view of the well-documented reduced rate of metabolism of many substances present in normal or reduced concentrations in the hypothyroid state (e.g., cortisol, thyroxine, digoxin). TSH appears to be more slowly metabolized than other pituitary hormones so far studied. Parker, Utiger, and Daugh-aday (17) have reported the tj of labeled and unlabeled exogenous growth hormone (GH) in man to be about 27 minutes. Glick, Roth, and Lonergan (18) have published similar tj values for the disappearance of endogenous plasma growth hormone in man. Parker and her colleagues (17) have also previously reported that the disappearance of GH-131I was initially rapid with a tj of about 27 minutes, during which about 80%o of the GH-131I disappeared. Later, the GH-'31I disappeared with a much longer ti, which was presumed to be due to the slower disappearance of damaged GH-131I. The t4 of disappearance of endogenous GH or administered unlabeled GH was similar to the early disappearance phase that occurred between 10 and 100 minutes. Liddle, Island, and Meador (19) have reported the tj of ACTH to be about 20 minutes.
The mean volume of distribution of TSH in our studies was 5.8%o of body weight, which is in remarkably good agreement with that calculated by Bakke and co-workers (7) after bovine TSH administration. This volume is also remarkably similar to that estimated for alpha melanocytestimulating hormone in the rat using distribution of unlabeled hormone (20) . This suggests that TSH is not uniformly distributed throughout the extracellular fluid volume. The total body pool of TSH averaged 6.1 jug (9.2 mU) in the euthyroid patients and was 7 to 15 times greater in the 3 hypothyroid patients studied. Measurements of plasma TSH by immunoassay in other hypothyroid patients have ranged from 6 to 230 m1ug per ml (9 to 345 PIU) (10, 11, 21) . If we assume that the mean euthyroid TSH pool size of 5.8% of body weight applies for all hypothyroid patients (and similar values were found in our 3 hypothyroid patients), the total TSH pool in 70-kg hypothyroid subjects would range from 24 to 920 Mig or from 2 to 290 times the limits of the normal range. Two reference standards were available to translate these values to units. The USP standard is of bovine origin and does not react in the immunoassay for human TSH. Furthermore the potency ratio of human TSH assayed against this USP standard varies depending on the species of assay animal. However, at the onset of these studies, our human TSH preparation had a potency of 10 USP U per mg in the chick assay of Bates (15 The secretion rate of TSH in the 3 hypothyroid patients studied was about 7 times that of the euthyroid subjects. It is apparent that the elevated TSH levels in circulating blood of hypothyroid patients result from both an increase in secretion rate and a reduction in degradation. If we used the average value for TSH volume of distribution, the average tj of 85 minutes, and a range of plasma TSH concentrations in hypothyroidism of 6 to 230 m,ug per ml, the secretion rate would range from about 260 to 15,350 utg per 24 hours.
